Skip to Content

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial COGAAML08B1


AAML08B1 - Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)

Principal Investigator(s)

Howard Katzenstein


  • Protocol No. COGAAML08B1
  • Open Date: 10/26/2011
  • Staging: N/A
  • Age Group: Children
  • Scope: National
  • Objective: Molecular features of TMD may influence outcome in Down syndrome patients and predict their risk of developing subsequent leukemia.
  • Disease Sites: Pediatrics; Pediatric Leukemia
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT00959283
  • Secondary Protocol No: AAML08B1


None Provided.


Not provided. Please call for more information.